Literature DB >> 16915161

Pulmonary blastomycosis masquerading as metastatic disease in the lung: a case report.

Bobbak Vahid1, Bernadette Wildemore, Christopher Nguyen, Niki Sistrun, Paul E Marik.   

Abstract

We report a case of pulmonary blastomycosis appearing as metastatic laryngeal squamous cell carcinoma. Pulmonary blastomycosis was discovered as right lower lobe subpleural activity consistent with metastatic disease on a positron emission tomographic (PET) scan following total laryngectomy and bilateral neck dissection for locally invasive laryngeal squamous cell carcinoma. A computed tomographic (CT) scan of the chest showed a right lower lobe, subpleural pulmonary nodule. CT-guided fine-needle aspiration of the nodule revealed broad-based budding yeast consistent with blastomycosis. To our knowledge, this is the first case of a PET-positive pulmonary blastomycosis lesion mimicking pulmonary malignancy reported in the literature.

Entities:  

Mesh:

Year:  2006        PMID: 16915161      PMCID: PMC1681996     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  22 in total

1.  Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin.

Authors:  B S Klein; J M Vergeront; L Kaufman; R W Bradsher; U N Kumar; G Mathai; B Varkey; J P Davis
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

2.  Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.

Authors:  S W Chapman; R W Bradsher; G D Campbell; P G Pappas; C A Kauffman
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

3.  Tracheal blastomycosis.

Authors:  J Kaufman
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

Review 4.  Reactivation and dissemination of blastomycosis complicating Hodgkin's disease: a case report and review of the literature.

Authors:  E W Winquist; S L Walmsley; N L Berinstein
Journal:  Am J Hematol       Date:  1993-06       Impact factor: 10.047

5.  In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

Authors:  N A Dewan; N C Gupta; L S Redepenning; J J Phalen; M P Frick
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

7.  Blastomycosis: pulmonary and pleural manifestations.

Authors:  P J Failla; F P Cerise; G H Karam; W R Summer
Journal:  South Med J       Date:  1995-04       Impact factor: 0.954

8.  Blastomycosis in immunocompromised patients.

Authors:  P G Pappas; M G Threlkeld; G D Bedsole; K O Cleveland; M S Gelfand; W E Dismukes
Journal:  Medicine (Baltimore)       Date:  1993-09       Impact factor: 1.889

Review 9.  Blastomycosis.

Authors:  R W Bradsher
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

10.  Fluorine-18-fluorodeoxyglucose uptake in pneumonia.

Authors:  L O Kapucu; C C Meltzer; D W Townsend; R J Keenan; J D Luketich
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

View more
  3 in total

1.  Disseminated paracoccidioidomycosis (simulating metastatic lung cancer) and Strongyloides stercoralis hyperinfestation in a steroid-treated patient.

Authors:  Aline Gehlen Dall Bello; Cecília Bittencourt Severo; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

Review 2.  Imaging fungal infections in children.

Authors:  Alfred O Ankrah; Mike M Sathekge; Rudi A J O Dierckx; Andor W J M Glaudemans
Journal:  Clin Transl Imaging       Date:  2016-01-25

3.  Pulmonary blastomycosis presenting as primary lung cancer.

Authors:  Syed Mohammed Qasim Hussaini; Deng Madut; Betty C Tong; Elizabeth N Pavlisko; Wiley A Schell; John R Perfect; Nathan M Thielman
Journal:  BMC Infect Dis       Date:  2018-07-18       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.